CME
Closing Arguments in the Case of Anti-CTLA-4-based Versus Anti-LAG3-based Frontline Combination ICI Treatment of Stage IV Melanoma
August 18, 2023
Host: Jeffrey S. Weber, MD, PhD Host: Sapna Patel, MD Host: Jason J. Luke, MD, FACP Despite improved prognosis for melanoma patients due to advances in treatment options in recent years, survival rates for patients with metastatic diseas
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!